Cryogenic Gas Solutions Drive Regenerative Therapies in Life Sciences

June 06, 2016

Innovation in the pharmaceutical industry is being led by regenerative therapies. Many of these new therapies need to be maintained at cryogenic conditions during storage and transport and cannot be supported by traditional shipping solutions. In this article, Tamie Joeckel, senior vice president, client services and consulting, explains how Cryoport’s shipping solutions support breakthrough treatments with technology as innovative as the treatments themselves. Read more >

Questions or comments? We welcome your feedback!

Email Us

Tags: Clinical Trials Logistics, Temperature Controlled Logistics, Cryoport News

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC